RecruitingPHASE1, PHASE2NCT07541209
Safety and Efficacy of PTH-IA
Studying Metaphyseal chondrodysplasia, Jansen type
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National Institute of Dental and Craniofacial Research (NIDCR)
- Principal Investigator
- Alison M Boyce, M.D.National Institute of Dental and Craniofacial Research (NIDCR)
- Intervention
- PTH-IA(drug)
- Enrollment
- 12 target
- Eligibility
- 3-100 years · All sexes
- Timeline
- 2026 – 2029
Study locations (1)
- National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07541209 on ClinicalTrials.gov